☆ 3.8 Meeting Abstract

Degarelix versus leuprolide in prostate cancer patients: new prostate-specific antigen data from a phase III trial (CS21)

EJC SUPPLEMENTS (2009)

Journal

EJC SUPPLEMENTS

Volume 7, Issue 2, Pages 411-411

Publisher

PERGAMON-ELSEVIER SCIENCE LTD

DOI: 10.1016/S1359-6349(09)71394-1

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.